The drug costs patients 129,000. The same cost for patients in other countries about a third of that amount. I realize the pharmaceutical Companies Invest their researches, they bring a new drug to market, they should profit from that innovation, but why are the u. S. Patients getti getting gauged for drugs. Can you better explain why u. S. Taxpayers are paying for Biomedical Research at the front end and paying exorbitant prices at the back end . Ill just say that 50 of my colleagues and myself sent a letter to you and secretary burwell requesting that they write when taxpair funded research leads to patent product not available to the public on reasonable terms . What are reasonable terms . A drug shouldnt cost 129,000 for people to get access to it. I know this is a topic of great interest, and while it should be and my heart goes out as all of us do to patients who are in need of a therapeutic which is outside of their financial means to be able to gain access to. That ought to be
Envela plans to open at least four stores by Q3 2023, aiming to double its retail business over the next 2 years. See the reasons for my rating upgrade of ELA.
Visiongain has published a new report entitled Solar Panel Recycling 2023-2033. It includes profiles of Solar Panel Recycling and Forecasts Market Segment by Product, (Silicon Based PV, Thin Film PV, Other PV Products) Market Segment by Waste T.
Visiongain has published a new report entitled Solar Panel Recycling 2023-2033. It includes profiles of Solar Panel Recycling and Forecasts Market Segment.
/PRNewswire/ The "Solar Panel Recycling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to.